Healthcare -
Biotechnology - NASDAQ - US
$ 14.5
0.625 %
$ 1.23 B
Market Cap
-8.95
P/E
LQDA - COST OF REVENUE
Cost of Revenue LQDA - Liquidia Corporation
2.89 M
LAST VALUE
-2.26%
2 YEAR CAGR
88.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR